DWP16001: Clinical Trials

12 trials of DWP16001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown, 4 completed. 12 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 112Unknown 8, Completed 4

Follow DWP16001: new trials by email Literature Review of DWP16001 trials Research Report on DWP16001

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults
DWP16001, DWC202511, DWC202512 - Healthy
Phase 1CompletedDaewoong Pharmaceutical Co. LTD.182025-11-092026-02-11
To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
DWP16001 - Diabetes Mellitus, Type 2
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.242023-04-132024-04-08
To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers
DWP16001 - Healthy
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.322023-03-092023-04-04
To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
DWC202213, DWJ1563, DWP16001 - FDC, Diabetes Mellitus, Type 2
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.402023-01-252023-02-21
Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults
DWP16001, DWC202204+DWC202205, DWP16001+DWC202204+DWC202205 - Healthy
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.532022-08-262022-08-15
A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
DWJ1525, DWP16001, DWC202101 - Healthy
Phase 1CompletedDaewoong Pharmaceutical Co. LTD.372022-04-152022-07-11
Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities
DWP16001 - Healthy
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.242022-02-142022-01-26
The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults
DWP16001, DWP202010 - Healthy Volunteers
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.242021-12-102022-04-11
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults
DWP16001, DWC202001+DWC202002, DWP16001+DWC202001+DWC202002 - Healthy
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.342020-04-012020-04-27
Type 2 Diabetes Patients With Renal Impairment
DWP16001 - Type2 Diabetes
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.352020-01-012020-01-09
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)
DWP16001, Metformin IR, DWP16001+Metformin IR - Healthy
Phase 1CompletedDaewoong Pharmaceutical Co. LTD.342019-08-142020-01-13
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers
DWP16001, Placebo, Dapagliflozin - Healthy
Phase 1CompletedDaewoong Pharmaceutical Co. LTD.1232017-12-032019-08-21

Conditions studied

Diabetes Mellitus, Type 2 (2)

Sponsors

Daewoong Pharmaceutical Co. LTD. (12)

Countries

South Korea (9)

Results publications

PMID 37593838, PMID 38618974